-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Vera Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2021 to Q4 2024.
- Vera Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2024 was 55.3M shares, a 29.5% increase year-over-year.
- Vera Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 55.3M shares, a 29.5% increase from 2023.
- Vera Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 42.7M shares, a 60.7% increase from 2022.
- Vera Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 26.6M shares, a 97.8% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)